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Abstract Vessel embolization can be a valuable adjunct
procedure in transjugular intrahepatic portosystemic shunt
(TIPS). During the creation of a TIPS, embolization of
portal vein collaterals supplying esophageal varices may
lower the risk of secondary rebleeding. And after creation
of a TIPS, closure of the TIPS itself may be indicated if the
resulting hepatic encephalopathy severely impairs mental
functioning. The Amplatzer Vascular Plug (AVP; AGA
Medical, Golden Valley, MN) is well suited for emboli-
zation of large-diameter vessels and has been employed in
a variety of vascular lesions including congenital arterio-
venous shunts. Here we describe the use of the AVP in the
context of TIPS to embolize portal vein collaterals (n = 8)
or to occlude the TIPS (n = 2).
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Portal vein collaterals supplying esophageal varices may
give high risk for secondary rebleeding. Those collaterals
might require embolization to decrease this risk, despite
transjugular intrahepatic portosystemic shunt (TIPS)
placement. Embolization of the collaterals may be partic-
ularly difficult when these vessels are large. Moreover,
after creation of a TIPS, closure of the TIPS itself may be
indicated when hepatic encephalopathy severely impairs
mental functioning. The Amplatzer Vascular Plug (AVP;
AGA Medical, Golden Valley, MN) is a device well suited
to embolize large vessels and has been employed in a
variety of vascular lesions such as pulmonary arteriovenous
malformations and congenital shunts [1, 2].
This report describes the use of the AVP in the context
of TIPS to embolize portal vein collaterals (n = 8) or to
occlude the TIPS (n = 2).
Description of Procedures
Embolization of Portal Vein Collaterals
Eight patients were referred for TIPS, seven because of
multiple recurrent bleeding episodes from esophageal
varices (n = 5), gastric fundus varices (n = 1), or both
(n = 1) that could not be managed by endoscopic therapy.
One other patient (n = 1) was in hypovolemic shock be-
cause of recurrent massive bleeding from rectal hemor-
rhoids. Three TIPS procedures were elective and five were
done as emergency procedures for uncontrolled bleeding
after initial hemodynamic stabilization had been achieved
using blood transfusions, endoscopic treatment, intrave-
nous octreotide infusion, and/or placement of a Sengstaken
double balloon tube, alone or in combination. TIPS pro-
cedures were carried out under general anesthesia.
As an adjunct procedure, we obliterated the portal vein
collaterals supplying the bleeding varices using AVP
embolization (Figs. 1 and 2). This was done either before
or after creation of the TIPS based on operator preference
and clinical circumstances. Embolization early in the pro-
cedure with early control of the potential bleeding site was
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considered relevant in emergency procedures in hemody-
namically unstable patients. Also, at least theoretically,
AVP embolization may be done more easily prior to TIPS
whenever the collateral target vein is still widened because
of portal hypertension and easily opacified because of
preferential flow. After the creation of a TIPS both these
phenomena may have been altered.
Whenever AVP embolization preceded TIPS placement,
the guiding catheter for AVP delivery was introduced
transhepatically into the right portal vein. At our institution
the portal vein is routinely catheterized prior to TIPS with a
3- or 4-Fr catheter to visualize the portal vein as a fluo-
roscopic target for transjugular transhepatic puncture. For
transhepatic AVP placement this catheter was exchanged
for a 6- to 8-Fr hepatic introducer sheath. After AVP
embolization and initial creation of the hepatic-to-portal
vein shunt tract for TIPS, the hepatic introducer sheath was
withdrawn in multiple small successive steps over the
course of the remainder of the procedure, so that a solid
sealing clot could form in the hepatic parenchymal tract.
No additional embolization of the tract was performed.
Whenever vein embolization was performed after the cre-
ation of a TIPS, AVP placement was done via the trans-
jugular route.
In all patients, the large-diameter coronary/gastric
vein supplying extensive esophageal/gastric varices was
embolized using a single AVP plug 10, 12, or 14 mm in
diameter. For placement, a 6- to 8-Fr guiding catheter was
first negotiated into the proximal part of the coronary vein.
Then the AVP device was advanced through the guiding
catheter and initially deployed by retracting the guiding
catheter but without detaching the device. A control
injection was made, and if needed, the AVP was retrieved
into the guiding catheter and repositioned. When in a sat-
isfactory position, the AVP was detached by anticlockwise
rotation of the AVP guide wire to unscrew it from the AVP
device proper. Within minutes of deployment, the collat-
eral flow through the coronary vein had completely
stopped. TIPS creation was done by placement of e-PTFE-
covered stent-grafts (Viatorr; Gore, Flagstaff, AZ) 8–10
mm in diameter and 6 ± 2 cm long, resulting in a post-
procedural portosystemic pressure difference of 5–10 mm
Hg. All patients were hemodynamically stable immediately
after the procedure.
During follow-up there were no recorded episodes of
rebleeding with a follow-up of 1 year maximum. The pa-
tient who was treated for bleeding rectal hemorrhoids died
after 3 days because of combined liver and respiratory
failure. Another patient who received emergency TIPS
Fig. 1 Portal venous angiogram in a 53-year-old patient referred for
TIPS creation because of recurrent variceal bleeding not controlled by
medication plus multiple treatments with endoscopic band ligation
and sclerotherapy. The varices are supplied by a single coronary vein
Fig. 2 The same patient as in
Fig. 1 immediately following
TIPS creation and AVP
embolization of the coronary
vein (a; thin arrow). The
unsubtracted image (b) shows
the radiopaque sclerosing agent
from prior endoscopic
sclerotherapy (fat arrow) in the
esophageal varices
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while in hypovolemic shock due to massive unstoppable
bleeding from esophageal varices died 46 days after the
procedure because of liver and kidney failure complicated
by ileus.
TIPS Occlusion
A 47-year-old male was referred for closure of a TIPS that
had been created 3 years earlier for alcoholic Child A liver
cirrhosis with recurrent episodes of esophagus variceal
bleeding. He now presented with problems of amnesia,
difficulties concentrating, and a general, overwhelming
feeling of tiredness. Spectral EEG findings were consistent
with grade 2 hepatic encephalopathy. The symptoms had
not improved using conservative treatment. At angiogra-
phy, a patent TIPS was seen, with a portosystemic pressure
difference of 10 mm Hg. Closure of the TIPS with a 14-mm
AVP device (Fig. 3) resulted in a dramatic improvement in
cognitive functioning and normalization of the spectral
EEG. Two years after closure of the TIPS, the patient is
still free of variceal bleeding. Recently, however, he
developed esophageal varices grades I–II, which are cur-
rently treated with band ligation. This will be repeated
every 2 weeks until complete obliteration.
Another patient, a 65-year-old male, had been referred
for TIPS placement for refractory ascites following liver
transplantation, which required weekly paracentesis. In the
days following placement of a 10-mm-diameter e-PTFE-
covered stent-graft TIPS, liver failure developed, necessi-
tating its closure. Closure of the TIPS was technically
successfully achieved using a 16-mm-diameter AVP but
did not substantially improve the clinical status. Because of
liver failure and refractory ascites, the patient underwent a
second liver transplantation 2 days after TIPS occlusion.
Discussion
In this report we have described the use of AVP emboli-
zation in the context of TIPS. For closure of collateral
veins supplying bleeding varices, we consider the AVP a
useful device in a defined subset of patients. The AVP’s
relative advantages are its efficiency to occlude large-
diameter vessels in a single-step procedure and its reli-
ability of placement. Unlike standard embolization coils,
the AVP can be positioned precisely, its position can be
checked with contrast injections before actual detachment,
and it can be repositioned if required. Migration of the
AVP during or after deployment is unlikely. Disadvantages
of the AVP include the higher cost of the device itself and
of the additionally required guiding catheter. Furthermore,
the 6- to 8-Fr guiding catheter markedly increases the bulk
of the introducer system relative to the 4- to 5-Fr catheter
alternatively used for coil embolization. In our practice we
are inclined to use the AVP whenever there is a single,
large-diameter collateral vein which would otherwise
require the insertions of multiple embolization coils and/or
whenever accurate placement of the embolic device close
to the portal vein may be critical.
Embolization of portal vein collaterals to esophageal
varices may be indicated even after successful portal
venous decompression by creation of a TIPS. Especially in
the life-threatening emergency situation of acute esopha-
geal bleeding in hemodynamically unstable patients, we
feel more confident providing additional control of the
bleeding site by hemodynamically separating the weak-
walled varices from the high-flow and potentially high-
pressure portal venous bed. TIPS has proven efficient in the
secondary prevention of variceal bleeding but this protec-
tion is not absolute. The rebleeding rate of TIPS alone
Fig. 3 AVP device for TIPS occlusion in a patient with life-
incapacitating hepatic encephalopathy. The 14-mm-diameter AVP is
positioned through a guiding catheter in the central portion of the 10-
mm-diameter e-PTFE stent-graft (a). By retraction of the guide wire,
the unconstrained AVP sets in the intended place (b). At this point,
the AVP can still be retracted into the guiding catheter if in an
unsatisfactory position. The AVP is fully deployed by unscrewing the
guide wire from the AVP device proper (c)
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(without embolization) has been reported as between 9%
and 40.6%, with a median of 18.4% [3]. These values apply
to bare-stented TIPS and initial experience suggests that
the rebleeding rate is lower with e-PTFE-covered stented
TIPS [4]. Whether or not performing embolization of the
portal vein collaterals as an adjunct procedure provides
additional protection against rebleeding is unknown. Under
the assumption that it does, we routinely combine TIPS
with embolization of all venous collaterals supplying the
esophageal varices when creating a TIPS in the context of
variceal bleeding.
Another potential use for the AVP device is for closure
of the TIPS itself, in circumstances where hepatic
encephalopathy and/or liver failure because of the shunt
may prove to be life-incapacitating. Here, the effectiveness
of the AVP in occluding large-diameter high-flow vessels,
its resistance to migration, and its ease of placement are
particularly helpful.
A potential concern when occluding a TIPS is the acute
increase in portal venous pressure, which can lead to
recurrence of variceal bleeding and ascites and, also, to
hemodynamic changes with increased cardiac loading [5].
As mentioned, we routinely place a transhepatic catheter
into the portal vein as a target for puncturing the portal vein
during TIPS creation. In our experience, this increases the
control over the exact entrance point into the portal vein
and also reduces the number of puncture attempts while
creating the TIPS tract. We have found that the reduced
procedure time for the TIPS procedure proper more than
makes up for the extra time it takes to insert this initial
transhepatic catheter into the portal vein. We have
encountered no complications because of this approach in
more than 100 TIPS procedures.
To our knowledge, this is the second reported use of
the AVP in the portal venous system. In a recent case
report, Kessler and Trerotola described a patient with
gastric varices and TIPS in whom they used the AVP
device for transhepatic obliteration of the portal vein
collateral supplying the varices [6], a patient similar to
one of our patients with flow-mediated gastric varices.
We would like to emphasize that the AVP may be con-
sidered also for embolization of the more common col-
lateral veins to esophageal varices and, if need be, the
TIPS stent itself.
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